Atlas Trials

Predictive Value of CHA2DS2VASC Score for Contrast-induced Nephropathy After Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction Patients

Clinical trial NCT04730778 · COMPLETED

Trial details

NCT number
NCT04730778
Sponsor
Cairo University
Status
COMPLETED
Study type
OBSERVATIONAL
Acute ST Segment Elevation Myocardial Infarction
Start date
2021-04-01
Primary completion
2022-12-15
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.